A few updates for you this week, including approval of Hemgenix for Hemophilia B, Rebyota for CDiff inflection, and Rezlidhia for refractory AML. Don’t forget to like, share, & subscribe! ENJOY!

A few updates for you this week, including approval of Hemgenix for Hemophilia B, Rebyota for CDiff inflection, and Rezlidhia for refractory AML. Don’t forget to like, share, &amp; subscribe! ENJOY!

Episode 87 - Hemgenix, Rebyota, & Rezlidhia

For healthcare providers especially pharmacists, nurses and physicians, we work to provide current information on drug updates, changes in the marketplace, and hot topics in the pharmacy industry.

Share Episode 87 - Hemgenix, Rebyota, & Rezlidhia

Sign up to save your podcasts

Episode 87 - Hemgenix, Rebyota, & Rezlidhia

Episode 87 - Hemgenix, Rebyota, & Rezlidhia